VERTEX PHARMACEUTICALS INC / MA Insider Trading for July 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for July 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 96.87 | 860 | 83,308 | 0 | |
| Jul 18 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 179.85 | 860 | 154,671 | 16,087 | 16.9 K to 16.1 K (-5.07 %) |
| Jul 18 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 96.87 | 860 | 83,308 | 16,947 | 16.1 K to 16.9 K (+5.35 %) |
| Jul 18 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 131.89 | 23,375 | 3,082,929 | 10,625 | |
| Jul 18 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 182.00 | 23,375 | 4,254,250 | 39,113 | 62.5 K to 39.1 K (-37.41 %) |
| Jul 18 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 131.89 | 23,375 | 3,082,929 | 62,488 | 39.1 K to 62.5 K (+59.76 %) |
| Jul 18 2018 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 249 | 0 | 8,836 | |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 96.87 | 1,719 | 166,520 | 0 | |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 96.87 | 12,031 | 1,165,443 | 1,719 | |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 181.88 | 219 | 39,832 | 46,662 | 46.9 K to 46.7 K (-0.47 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 180.14 | 1,500 | 270,210 | 46,881 | 48.4 K to 46.9 K (-3.10 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 96.87 | 1,719 | 166,520 | 48,381 | 46.7 K to 48.4 K (+3.68 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 180.00 | 12,031 | 2,165,580 | 46,662 | 58.7 K to 46.7 K (-20.50 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 96.87 | 12,031 | 1,165,443 | 58,693 | 46.7 K to 58.7 K (+25.78 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 96.87 | 2,125 | 205,849 | 0 | |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 131.89 | 6,375 | 840,799 | 10,625 | |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 179.85 | 2,125 | 382,181 | 46,752 | 48.9 K to 46.8 K (-4.35 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 96.87 | 2,125 | 205,849 | 48,877 | 46.8 K to 48.9 K (+4.55 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 179.00 | 6,375 | 1,141,125 | 46,752 | 53.1 K to 46.8 K (-12.00 %) |
| Jul 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 131.89 | 6,375 | 840,799 | 53,127 | 46.8 K to 53.1 K (+13.64 %) |
| Jul 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 90.29 | 2,125 | 191,866 | 17,000 | |
| Jul 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 175.02 | 2,125 | 371,918 | 39,609 | 41.7 K to 39.6 K (-5.09 %) |
| Jul 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 90.29 | 2,125 | 191,866 | 41,734 | 39.6 K to 41.7 K (+5.36 %) |
| Jul 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 90.29 | 860 | 77,649 | 6,875 | |
| Jul 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 175.02 | 860 | 150,517 | 16,087 | 16.9 K to 16.1 K (-5.07 %) |
| Jul 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 90.29 | 860 | 77,649 | 16,947 | 16.1 K to 16.9 K (+5.35 %) |
| Jul 09 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 122.45 | 4,250 | 520,413 | 25,500 | |
| Jul 09 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 168.38 | 4,250 | 715,615 | 39,609 | 43.9 K to 39.6 K (-9.69 %) |
| Jul 09 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 122.45 | 4,250 | 520,413 | 43,859 | 39.6 K to 43.9 K (+10.73 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 131.89 | 23,375 | 3,082,929 | 10,625 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 166.57 | 18,634 | 3,103,865 | 46,699 | 65.3 K to 46.7 K (-28.52 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 165.22 | 4,741 | 783,308 | 65,333 | 70.1 K to 65.3 K (-6.77 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 131.89 | 23,375 | 3,082,929 | 70,074 | 46.7 K to 70.1 K (+50.05 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 17,086 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 15,086 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 169.00 | 3,708 | 626,652 | 46,752 | 50.5 K to 46.8 K (-7.35 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 1,553 | 134,366 | 50,460 | 48.9 K to 50.5 K (+3.18 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 2,155 | 196,213 | 48,907 | 46.8 K to 48.9 K (+4.61 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 86.52 | 809 | 69,995 | 8,899 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 91.05 | 1,289 | 117,363 | 9,024 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 96.87 | 859 | 83,211 | 860 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 161.57 | 809 | 130,710 | 16,087 | 16.9 K to 16.1 K (-4.79 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 86.52 | 809 | 69,995 | 16,896 | 16.1 K to 16.9 K (+5.03 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 166.05 | 1,289 | 214,038 | 16,087 | 17.4 K to 16.1 K (-7.42 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 91.05 | 1,289 | 117,363 | 17,376 | 16.1 K to 17.4 K (+8.01 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 171.87 | 859 | 147,636 | 16,087 | 16.9 K to 16.1 K (-5.07 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 96.87 | 859 | 83,211 | 16,946 | 16.1 K to 16.9 K (+5.34 %) |